Ticker LaunchLondon · AIM · Introduction · 4BB
4basebio UK Societas
4basebio UK Societas (4BB) was admitted to AIM on Feb 17, 2021 by way of introduction, without raising new money at 118p per share. Its market capitalization at admission was about £14.5M. Cairn Financial Advisers acted as nominated adviser, with finnCap as broker.
4basebio is a Cambridge-based life sciences group developing synthetic high-purity therapeutic DNA for gene therapies and DNA vaccines, plus delivery solutions. It was separated from German-listed 4basebio AG.
- Type
- Introduction
- Market
- AIM
- Ticker (TIDM)
- 4BB
- Admitted
- Feb 17, 2021
- Offer price
- 118p
- Market cap at admission
- £14.5M
- Nominated adviser
- Cairn Financial Advisers
- Brokers
- finnCap
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Cellular Goods plcMain Market · Feb 26, 2021
- Auction Technology Group plcMain Market · Feb 26, 2021
- Cornish Metals Inc.AIM · Feb 16, 2021
- Cordiant Digital Infrastructure LimitedMain Market · Feb 16, 2021
- MGC PharmaceuticalsMain Market · Feb 9, 2021
- Foresight Group Holdings LimitedMain Market · Feb 9, 2021